1. C. Shih, L. C. Padhy, M. Murray, and R. A. Weinberg (1981). Transforming gene of carcinomas and neuroblastomas introduced into mouse fibroblasts.Nature 290:261–264.
2. D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire (1987). Human breast cancer: correlation of relapse and survival with amplification of theHER-2/neu oncogene.Science 235:177–182.
3. M. S. Berger, G. W. Locher, S. Saurer, W. J. Gullick, M. D. Waterfield, B. Groner, and N. E. Hynes (1988). Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.Cancer Res. 48:1238–1243.
4. D. J. Slamon, W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press (1989). Studies of theHER-2/neu protooncogene in human breast and ovarian cancer.Science 244:707–712.
5. J.-B. Park, J. S. Rhim, S.-C. Park, S. W. Kimm, and M. H. Kraus (1989). Amplification, overexpression and rearrangement of theerbB-2 protooncogene in primary human stomach carcinomas.Cancer Res. 49:6605–6609.